Vishwadeep Shelke

4PUBLICATIONS
6CO-AUTHORS
Major global burdens of diseasePharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 27, 2025
Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress.

Tahib Habshi, Hrushikesh Kulkarni, Neha Dagar

|Jan 20, 2024
Phloretin: a comprehensive review of its potential against diabetes and associated complications.

Vishwadeep Shelke, Ajinath Kale, Yogesh A Kulkarni

|Oct 27, 2023
Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis.

Ajinath Kale, Vishwadeep Shelke, Yutian Lei

|May 23, 2023
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury.

Vishwadeep Shelke, Ajinath Kale, Neha Dagar

Pageof 1

Frequent Collaborators

2 joint publications

Anil Bhanudas Gaikwad

1 joint publications

Hans-Joachim Anders

1 joint publications

Yogesh A Kulkarni

1 joint publications

Tahib Habshi